Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Simon J. Hogg, Olga Motorna, Leonie A. Cluse, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2183-2200.e13
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Modulation of cellular processes by histone and non-histone protein acetylation
Maria Shvedunova, Asifa Akhtar
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 5, pp. 329-349
Closed Access | Times Cited: 519
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
Qingjuan Chen, Bin-Hui Yang, Xiaochen Liu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4935-4948
Open Access | Times Cited: 112
Chromatin accessibility: methods, mechanisms, and biological insights
Andrés Mansisidor, Viviana I. Risca
Nucleus (2022) Vol. 13, Iss. 1, pp. 238-278
Open Access | Times Cited: 73
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
Yu Zhu, Zi Wang, Yanan Li, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1219-1219
Open Access | Times Cited: 51
LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity
Jiangtao Cui, Yikun Wang, Xiaoting Tian, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 7-9, pp. 491-511
Closed Access | Times Cited: 46
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Pharmacological targeting of the cancer epigenome
Nathaniel W. Mabe, Jennifer A. Perry, Clare F. Malone, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 844-865
Closed Access | Times Cited: 20
Epigenetic regulation in cancer
Minzhi Gu, Bo Ren, Yuan Fang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 18
Targeting transcription cycles in cancer
Stephin J. Vervoort, Jennifer R. Devlin, Nicholas Kwiatkowski, et al.
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 5-24
Closed Access | Times Cited: 102
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
Aaron Waddell, Haojie Huang, Daiqing Liao
Cancers (2021) Vol. 13, Iss. 12, pp. 2872-2872
Open Access | Times Cited: 72
Now open: Evolving insights to the roles of lysine acetylation in chromatin organization and function
Joseph C. Y. Chen, Evangelia Koutelou, Sharon Dent
Molecular Cell (2022) Vol. 82, Iss. 4, pp. 716-727
Open Access | Times Cited: 58
Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification
Qingmei Zeng, Kun Wang, Yongxiang Zhao, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 417-417
Open Access | Times Cited: 32
Epigenetic moonlighting: Catalytic-independent functions of histone modifiers in regulating transcription
Marc A. Morgan, Ali Shilatifard
Science Advances (2023) Vol. 9, Iss. 16
Open Access | Times Cited: 30
Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment
Panhong Gou, Wenchao Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116130-116130
Open Access | Times Cited: 12
Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression
Rong He, Yifan Liu, Weijie Fu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
TEAD1::NCOA2 fusion driver in primary central nervous system malignancy: case report
Agnesa Panferova, М. А. Сенченко, Margarita Zaytseva, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Closed Access | Times Cited: 1
BANCR-Containing Extracellular Vesicles Enhance Breast Cancer Resistance
Xinming Song, Shen Liu, Ying Zeng, et al.
Journal of Biological Chemistry (2025), pp. 108304-108304
Open Access | Times Cited: 1
Targeting epigenetic modulators using PROTAC degraders: Current status and future perspective
Thomas Webb, Conner Craigon, Alessio Ciulli
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 63, pp. 128653-128653
Open Access | Times Cited: 37
Structural insights into p300 regulation and acetylation-dependent genome organisation
Ziad Ibrahim, Tao Wang, Olivier Destaing, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
HDACs and the epigenetic plasticity of cancer cells: Target the complexity
Claudio Brancolini, Teresa Gagliano, Martina Minisini
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108190-108190
Open Access | Times Cited: 32
CRISPR screens identify gene targets at breast cancer risk loci
Natasha Tuano, Jonathan Beesley, Murray Manning, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Acetyl-CoA metabolism as a therapeutic target for cancer
Guo Chen, Banghe Bao, Cheng Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115741-115741
Open Access | Times Cited: 21
Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition
Timothy R. Bishop, Chitra Subramanian, Eric M. Bilotta, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1215-1222
Open Access | Times Cited: 19
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer
Xianteng Wang, Xingkai Li, Liman Niu, et al.
Oncogene (2024) Vol. 43, Iss. 22, pp. 1669-1687
Closed Access | Times Cited: 6
The role of protein acetylation in carcinogenesis and targeted drug discovery
Jingru Yang, Cong Song, Xianquan Zhan
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top